Friction in the Path to Use of Biosimilar Drugs

N Engl J Med. 2018 May 31;378(22):2148. doi: 10.1056/NEJMc1805092.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals*
  • Friction*

Substances

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals